Breast cancer
Conditions
Interventions
Case series:Dalceli: 150mg orally, every 28 days is a treatment cycle, in which the first 3 weeks (day 1 to day 21) are taken continuously, and the last 1 week (day 22 to day 28) is rested (no medicat
Sponsors
The First Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Postmenopausal or premenopausal/perimenopausal female patients >=18 years old, who meet one of the following: (1) bilateral ovariectomy has been performed in the past, or the age is >=60 years old; (2) Age = 1% (verified by the researchers in the experimental center); 3. The score of the physical condition of Eastern Cancer Cooperative Group (ECOG) is 0-2; 4. Women of childbearing age must have a serum pregnancy test within 28 days before joining the group, and the result is negative, and they are willing to adopt a medically recognized high-efficiency contraceptive measure during the study period and within one year after the last administration of the study drug; 5. Patients who have already started to receive the treatment plan containing dalcicil before joining the group can also join the study if the baseline information, previous treatment and tumor curative effect evaluation information of the patients are complete; 6. With my consent and signed informed consent, I am willing and able to follow the planned visit, research and treatment plan, laboratory examination and other test procedures;
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating female patients; 2. Patients who are participating in other studies; 3. The researcher thinks it is not suitable for the selected patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events (AE);Severe adverse events (SAE); | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival (PFS);Overall survival (OS);Objective response rate (ORR);Clinical benefit rate (CBR); | — |
Countries
China
Contacts
Public ContactZhong Jincai
The First Affiliated Hospital of Guangxi Medical University
Outcome results
None listed